Search
Search

Wolen Lecture 2025: Rough Justice, Wicked Problems: Using AI to Decide Who Gets Extremely Expensive Treatments

Organisation

Indiana University Center for Bioethics

Location

Vannuys Medical Science Building Room 326/Online

End

In the 2025 Robert L Wolen Lecture in Bioethics, Leonard Fleck, PhD, will explore the “wicked problem” of using of AI to guide allocation of healthcare resources.

Every two years the IU Center for Bioethics partners with the IUSM Department of Pharmacology and Toxicology to invite an outstanding individual in the field of bioethics and the conduct of principled science to be the Robert L. Wolen Lecturer in Bioethics.

Event start time: 03:30 pm

Event end time: 04:30 pm

Related posts

Heartstrings and Hardware: Navigating the Ethics of LOVOTs in Elder Care

A group of researchers at the University of British Columbia’s IDEA Lab recently invited older adults living with dementia and their family care partners to sit with, hold, and observe an unlikely new inhabitant of long-term care: the soft-bodied, wide-eyed companion robot known as LOVOT. In their recent critical reflection study, published in Digital Health, the authors […]

Virtual Reality in Medical Education: Can Empathy Become a Simulation?

Medical education has always relied on simulators. From wooden mannequins in the 17th century to the digital cadavers of today, physicians have long used different tools to practice care without consequence. But virtual reality (VR) changes the moral equation. When a headset can recreate the tremor of an elderly hand, the panic of an asthma […]

Building Consensus for Responsible AI in Healthcare

This editorial appears in the October 2025 issue of the American Journal of Bioethics Although AI in healthcare depends on collaboration across disciplines, those involved in its development and implementation can operate in silos, having limited insight into one another’s practices. A shared framework is therefore important for harmonizing best practices across a growing range of specialties, […]

Prescribing Ozempic and an Obligation to Lose Weight

  Prescriptions of GLP-1 drugs to patients without diabetes have seen an increase of 700% since 2019. GLP-1 drugs like Ozempic and Mounjaro were originally used to treat Type 2 diabetes and to reduce the risks of heart attack and stroke. Now they are also prescribed off-label for the purpose of weight loss, especially for […]

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Privacy Policy. By closing this message, you are consenting to our use of cookies.

close